共 22 条
[1]
ABE O, 1992, LANCET, V339, P71
[2]
[Anonymous], 1985, JAMA, V254, P3461
[3]
[Anonymous], BREAST CANC RES TREA
[4]
Carlson R W, 1997, Semin Oncol, V24, pS1
[5]
Clarke M, 1998, LANCET, V351, P1451
[7]
Early stopping of a clinical trial when there is evidence of no treatment benefit: Protocol B-14 of the National Surgical Adjuvant Breast and Bowel Project
[J].
CONTROLLED CLINICAL TRIALS,
1998, 19 (06)
:575-588
[8]
Earl H, 1997, Clin Oncol (R Coll Radiol), V9, P141, DOI 10.1016/S0936-6555(97)80067-2
[9]
Five versus more than five years of tamoxifen for lymph node-negative breast cancer: Updated findings from the National Surgical Adjuvant Breast and Bowel Project B-14 randomized trial
[J].
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE,
2001, 93 (09)
:684-690
[10]
Five versus more than five years of tamoxifen therapy for breast cancer patients with negative lymph nodes and estrogen receptor-positive tumors
[J].
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE,
1996, 88 (21)
:1529-1542